Evidence map›Paper›PMID 41383770›Full record

ArticlebioRxiv : the preprint server for biology2025

A generalizable cross-continent prediction of esophageal squamous cell carcinoma using the oral microbiome.

Shahd ElNaggar, Wenlong Carl Chen, Leanne M Prodehl, Thomas K Marumo, Muhammed U Khan, Christopher G Mathew, Paul Ruff, Zhezhen Jin, Alfred I Neugut, Anil K Rustgi and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Shahd ElNaggarProgram for Mathematical Genomics, Department of Systems Biology, Columbia University Irving Medical Center, New York, NY.ORCID 0000-0003-1068-1578
Wenlong Carl ChenStrengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Leanne M ProdehlSurgical Gastroenterology Unit, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
Thomas K MarumoSurgical Gastroenterology Unit, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
Muhammed U KhanSurgical Gastroenterology Unit, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
Christopher G MathewSydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Paul RuffSouth African Medical Research Council Common Epithelial Cancer Research Centre, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Zhezhen JinDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY.
Alfred I NeugutDepartment of Medicine, Columbia University Irving Medical Center, New York, NY.
Anil K RustgiDepartment of Medicine, Columbia University Irving Medical Center, New York, NY.
Anne-Catrin UhlemannDepartment of Medicine, Columbia University Irving Medical Center, New York, NY.
Tal KoremProgram for Mathematical Genomics, Department of Systems Biology, Columbia University Irving Medical Center, New York, NY.ORCID 0000-0002-0609-0858
Julian A AbramsDepartment of Medicine, Columbia University Irving Medical Center, New York, NY.

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
The Oral Microbiome for the Detection of Barretts EsophagusR01CA238433 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ABRAMS, JULIAN · 2019 to 2023
$2.6M
NCI NIH HHS P30 CA013696NCI NIH HHS R01 CA238433Wellcome Trust
6 · The paper itself

Abstract

Esophageal squamous cell carcinoma (ESCC) is a disease with limited tools for early screening and a poor prognosis. Symptoms typically appear late, and early cancer is hard to detect without endoscopic screening, which is inaccessible in most high-risk areas. Saliva is easily accessible, and its microbiome composition can serve as a marker for upper gastrointestinal tract disease. We studied the potential utility of an oral microbiome signature for ESCC in South Africa, a region with a high incidence of the disease. In a cohort of 48 ESCC patients and 110 controls, we found marked alterations in the oral microbiome in patients with ESCC, including significantly reduced alpha diversity and increased

Identifiers

PMID41383770
PMCPMC12694582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.